What’s new

• Consolidated revenue grew 4.3% to ₹2,202 cr in FY26.
• Profit before exceptional items dropped to ₹90.5 cr from ₹154.6 cr due to labour code charges.
• Standalone revenue fell 18.6% to ₹1,412 cr, but net profit stayed at ₹158.9 cr thanks to a land sale.

Why it matters

The core performance cooled as one-time charges hit the bottom line. Investors should ignore the standalone profit boost from asset sales and focus on the consolidated margin pressure.

What we’re watching

• Whether operating margins rise now that the one-time labour charge is settled.
• The trajectory of standalone revenue following the 18.6% drop.
• The recurring cost impact of new labour code compliance.

The full read

Unichem Laboratories reported a split FY26 performance. Consolidated revenue ticked up 4.3% to ₹2,202 crore. Profit before exceptional items slid from ₹154.6 crore to ₹90.5 crore. This compression reflects one-time labour code expenses. Standalone operations saw an 18.6% drop in revenue to ₹1,412 crore. Net profit here remained flat at ₹158.9 crore, propped up by a land sale. These results confirm trends from previous quarterly updates. With the labour charge settled and the asset gain realized, the question is whether the core business can hold margins without help from asset disposals. Growth must recover from the standalone decline to change the current outlook.

Primary source: BSE · NSE